Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fondaparinux as Monotherapy for Deep Vein Thrombosis and/or Pulmonary Embolism (Pilot Study)

NCT00413504 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT00413504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00413504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fondaparinux as Monotherapy for Deep Vein Thrombosis and/or Pulmonary Embolism (Pilot Study)
Lead sponsor
Brigham and Women's Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2006
Completion date
July 31, 2007
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, pulmonary embolism